How mass spectrometry-based proteomics
accelerate drug discovery and development

Missed it live?

Watch on demand!

Overview

Identifying and quantifying thousands of proteins is a major challenge in many drug discovery and development projects. Mass spectrometry-based proteomics offers powerful tools to support target validation, understand disease mechanisms, and explore potential biomarkers.

In this webinar, we’ll walk through how proteomics can support your research – from experimental design and sample preparation to data acquisition and analysis. You’ll learn what proteomics can and cannot deliver, how to avoid common challenges, and how to interpret the results effectively. We’ll also share practical insights from our daily work with proteomics data, including examples relevant to drug discovery and development.

Whether you're already using proteomics or just starting to explore its potential, this session will provide valuable guidance to help you get the most out of your data.

 

CQ1A6480_grade_thumb
Selvita Expert

Meet Our Speaker

alex_601x601px

Alexander Moysa, PhD

Analytical Expert

Alexander Moysa, PhD, is a biochemist with over a decade of experience spanning both academia and industry, specializing in mass spectrometry-based proteomics and metabolomics. He has deep expertise in LC-MS method development and proteomics data analysis, and a strong track record of supporting drug development and discovery through advanced analytical strategies. Alexander works as an Analytical Expert at Selvita, where he leads complex studies and ensures high-impact scientific outcomes for pharmaceutical clients.

Asset-1@4x-1
About Selvita
Learn more
Asset-3@4x-1
Drug Development
Explore now
Asset-2@4x-1
Drug Discovery
Explore now